Credo Biomedical

Credo Biomedical Develops Point-of-Care (POC) Technology. Their nucleic acid diagnostic platform is designed for use by individuals with minimal training. The company focuses on the research and development of revolutionary diagnostic technologies, developing, manufacturing, and commercializing an accurate, rapid, and affordable molecular diagnostic platform on the QubeMDx care tool.